IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation

Trial Profile

IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation

Discontinued
Phase of Trial: Phase II

Latest Information Update: 28 Jan 2016

At a glance

  • Drugs Botulinum toxin A (Primary) ; Botulinum toxin A (Primary)
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Dec 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
    • 13 Apr 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2015 to 1 Jul 2016.
    • 13 Apr 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Dec 2014 to 1 Jul 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top